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DObjective: Despite numerous randomized and nonrandomized trials on off- and on-pump coronary artery bypass
grafting, it remains open which method is superior. Patient selection and small sample sizes limit the evidence
from randomized trials; lack of randomization limits the evidence from nonrandomized trials. Propensity score
analyses are expected to improve on at least some of these problems. We aimed to systematically review all pro-
pensity score analyses comparing off- and on-pump coronary artery bypass grafting.
Methods: Propensity score analyses comparing off- and on-pump surgery were identified from 8 bibliographic
databases, citation tracking, and a free web search. Two independent reviewers abstracted data on 11 binary short-
term outcomes.
Results: A total of 35 of 58 initially retrieved propensity score analyses were included, accounting for a total of
123,137 patients. The estimated overall odds ratio was less than 1 for all outcomes, favoring off-pump surgery.
This benefit was statistically significant for mortality (odds ratio, 0.69; 95% confidence interval, 0.60–0.75),
stroke, renal failure, red blood cell transfusion (P< .0001), wound infection (P< .001), prolonged ventilation
(P<.01), inotropic support (P ¼ .02), and intraaortic balloon pump support (P ¼ .05). The odds ratios for myo-
cardial infarction, atrial fibrillation, and reoperation for bleeding were not significant.
Conclusions: Our systematic review and meta-analysis of propensity score analyses finds off-pump surgery supe-
rior to on-pump surgery in all of the assessed short-term outcomes. This advantage was statistically significant and
clinically relevant for most outcomes, especially for mortality, the most valid criterion. These results agree with pre-
vious systematic reviews of randomized and nonrandomized trials. (J Thorac Cardiovasc Surg 2010;140:829-35)Supplemental material is available online.
Coronary artery disease is still the most frequent cause of
death in industrialized countries. In middle-aged cohorts,
coronary artery disease has a prevalence of approximately
20%. More than 50,000 patients undergo coronary artery
bypass grafting (CABG) in Germany annually. There is
a trend to higher patient age and an increasing prevalence
of comorbidities.1 Today’s surgical standard involves coro-
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The Journal of Thoracic and Cacardioplegia-induced cardiac arrest, the so-called on-pump
technique. Although this technique is routinely used, there
are still morbidity and mortality risks, attributed to a systemic
inflammatory response and to atheromatous macroemboli-
zation. Because of these adverse side effects, the standard
technique has been challenged in recent years by the emerg-
ing off-pump technique, which avoids the use of cardiopul-
monary bypass and cardioplegia. The question of which
method is superior is one of the most hotly debated and
polarizing issues in cardiac surgery.2
Because of the public health and economic impacts of this
question, a large number of randomized clinical trials
(RCTs) were conducted. Most of them are summarized in
systematic reviews.3,4 These systematic reviews show
a trend toward an advantage of off-pump surgery in terms
of the clinically relevant postoperative outcomes mortality,
stroke, and myocardial infarction. The observed effects are
not always found to be statistically significant, mostly
because of limited sample sizes.
In addition to these RCTs, a number of nonrandomized
trials have been conducted. The respective data were also
collected in a systematic review.5 It is commonly agreed
that results from observational studies should not be used
for making treatment recommendations. Nonrandomized
studies, however, avoid 2 important deficiencies of RCTs.
First, RCTs are frequently conducted in highly selected
patient groups,6 enrolling patients who are younger andrdiovascular Surgery c Volume 140, Number 4 829
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Dhealthier than the average patient.7 Second, and this is of
special concern in cardiac surgery, clinically relevant out-
comes are only rarely observed. That is, RCTs intended to
find differences between treatments require large sample
sizes to detect differences between those rarely occurring
outcomes. For example, a study designed to detect a postop-
erative mortality reduction from 3% to 2%with 80% power
and 5% type I error would require more than 8000 patients.
This number should be compared with the sample size of the
largest RCTs published up to date,8 which included 388 pa-
tients. The number of patients included in the largest system-
atic review of RCTs to date was 5537 (from 66 trials).4
Therefore, not even the largest systematic reviews on this
topic would have enough power to find the postulated
difference in postoperative mortality.
Lack of randomization is of course the reason for distrust-
ing observational studies as a basis for treatment recommen-
dations. Randomization ensures that all relevant (known and
unknown) prognostic and risk factors are balanced across
treatment groups. In observational studies, we have to rely
on statistical methods such as stratification, matching, or
multivariate adjustment to adjust for baseline differences
in treatment groups. A promising technique for this adjust-
ment is the so-called propensity score method, which, if con-
ducted with matching on the propensity score, achieves
a kind of pseudorandomization. This ensures that at least
the known and measured prognostic factors are balanced.
The propensity score method, proposed as early as the
1980s,9 has only recently been applied to clinical research,
but sees increasing use, especially in cardiology and cardiac
surgery.10 Moreover, there are indications that the propen-
sity score method is statistically superior to the standard
methods for multivariate adjustment,11,12 especially when
the number of events is low as in CABG.12
In the following, we report on a systematic review and
meta-analysis comparing off-pump and on-pump CABG
explicitly including only propensity score analyses.
MATERIALS AND METHODS
Search Strategy
Searches were conducted independently by 2 persons (O.K., biostatisti-
cian; B.v.S., medical student) in the first week of February 2006. Our search
strategy was 3-fold: First, we searched the literature databases MEDLINE,
EMBASE, American College of Physicians Journal Club, Cochrane Central
Register of Controlled Trials, Cochrane Database of Systematic Reviews,830 The Journal of Thoracic and Cardiovascular SurgDatabase of Abstracts of Reviews of Effects, EBM Reviews, and Web of
Science for the keywords ‘‘Propensity’’ and ‘‘Off-Pump.’’ Second, we an-
alyzed the citations of 6 methodical articles9,13-17 on propensity score anal-
ysis via Web of Science (http://www.isiknowledge.com) because there is
evidence that failure to use citation tracking may cause bias from
overlooked studies.18 Third, we searched the open web-based scientific
databases Google scholar (http://scholar.google.com), Scirus (http://www.
scirus.com), and Vivı´simo clustering (http://vivisimo.com), also with the
keywords ‘‘Propensity’’ and ‘‘Off-Pump.’’ Finally, we checked the
references of all available articles. Meeting abstracts and unpublished
reports were included. Authors of meeting abstracts were contacted by
e-mail for additional information on the described studies. There were no
restrictions on language or time of publication.Data Collection and Management
Full-text versions of all initially retrieved publications were read inde-
pendently by 2 reviewers (O.K., B.v.S.). Data were abstracted into a self-
developed case report form, which had been tested in a small pilot review
encompassing 5 studies. The data collected by both reviewers were entered
in a database, and disagreements were located by automatic comparisons.
Agreement between reviewers was checked on a previously selected sub-
group of abstracted items (inclusion of study, high-risk population, type
of propensity analysis, reporting of confounders in the propensity score
model). All disagreements on abstracted data were resolved by consensus
and by discussion with a third reviewer (J.B.).Inclusion Criteria
Studies were included in the meta-analysis if they reported a comparison
of at least an off-pump with an on-pump group and made use of a propensity
score analysis for comparing treatments. Randomized controlled trials,
observational studies without a propensity score analysis, and systematic
reviews with no new original data were excluded. For inclusion, studies
also had to provide at least one of the binary clinical outcomes mortality,
stroke, myocardial infarction, atrial fibrillation, renal failure, inotropic
support, red blood cell (RBC) transfusion, wound infection, reoperation
for bleeding, intraaortic balloon pump support, or prolonged ventilation.
Only short-term or in-hospital outcomes were considered. Studies with
mere experimental outcomes were excluded. We always kept the outcome
definitions of the original researchers. Double publications were removed,
but data from the same study populations were included if these populations
did not completely overlap in the propensity score analyses.
Statistical Methods
For descriptive purposes, absolute and relative frequencies are reported
for categoric variates. The odds ratio (OR) was used to describe treatment
effects. From studies using regression adjustment or stratification in the pro-
pensity score analysis, the ORs with the corresponding confidence intervals
(CIs) were extracted directly from the text. In studies with a matched pro-
pensity score analysis, we used the absolute numbers of events and calcu-
lated ORs with CIs using standard methods. Studies with zero events
were corrected by the ‘‘reciprocal of the opposite treatment arm’’ method.19
In one study a relative risk was used to describe the treatment effect.
Because ORs and relative risks are approximately equal for rare outcomes,
we equated this relative risk with an OR.
For combining ORs from different studies, the random effects inverse-
variance method20 was applied, that is, ORs from the individual studies
were combined as weighted averages. The random effects method, com-
pared with the fixed effects method, was chosen because it allows heteroge-
neous treatment effects between studies and is slightly more conservative.
However, as a sensitivity analysis, the fixed effects estimates are also
presented. All calculations were performed with log-transformed ORs,
and results were retransformed for presentation. Although it is well known
that the inverse-variance method has deficiencies, we emphasize that it is theery c October 2010
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Donly method applicable with our approach where absolute numbers of
events are only available in cases of matched propensity score analyses.
To facilitate interpretation of results, we also computed summary numbers
needed to treat (number needed to treat with off-pump surgery to avoid 1
additional event) for each clinical outcome. Numbers needed to treat were
derived from the combined ORs using the ideas of Zhang and Yu.21 The re-
quired baseline risk data were calculated from the studies that reported
a matched propensity score analysis, because absolute frequencies are
only available in these cases. To assess heterogeneity between studies, we
performed the standard test for homogeneity (based on Cochran’s Q)20
and the recently proposed I2 statistic.
Meta-regression on location of study (Northern America vs others), type
of propensity score analysis (matching vs nonmatching), population risk
(high risk vs standard risk), volume per year (defined as the number of pa-
tients divided by the length of the observation period, but only in single-cen-
ter studies), and percentage of off-pump cases in the general study
population (not necessarily equal to this percentage in the propensity score
population) was conducted to judge the influence of these factors on hetero-
geneity. For this meta-regression, all outcomes were combined in a single
data set, and the analysis was adjusted for correlated (within study) out-
comes by using a random effects model.20 All statistical estimates are given
with their 95% CIs. The study database was programmed in Microsoft
ACCESS (Microsoft Corp, Redmond, Wash), and all statistical analyses
were conducted with SAS, 9.1.2. (SAS Institute Inc, Cary, NC).•
narratively (n=1) 
were already publicated (n=1) 
Publications appropriate 
for inclusion in meta-
analyses (n=35) 
FIGURE 1. Flow diagram of initially retrieved and eventually included
studies. PS, Propensity score.RESULTS
The initial search yielded 58 publications, of which 39
(66%) were found in the described literature databases, 8
(14%) were found by citation tracking, and 11 (19%)
were found in the open scientific databases.
Thirty-five of the initial 58 publications (60%) were in-
cluded in the final analyses (Table E1), 24 (69%) from the
described literature databases, 3 (9%) from citation tracking,
and 8 (22%) from the open scientific databases (Figure 1).
Five publications were excluded because they did not com-
pare an off-pump with an on-pump group; 6 publications
were excluded because they made no or wrong use of the
propensity score method; and 4 publications were systematic
reviews without new original data. In 6 publications, no in-
formation was given on the prespecified outcomes, and in 1
publication results from the propensity score analysis were
given only narratively. One publication was removed
because of double publication.
Table 1 provides an overview of the included studies:
Sixteen studies (46%) were conducted in Europe, and the
remaining were conducted in Northern America. Authors
of 19 propensity score analyses (54%) reported on a high-
risk population. The 35 studies account for a total of
123,137 observations; 49,718 procedures (40.4%) were
conducted off-pump. The online supplement shows the esti-
mated ORs for the single studies numerically (Table E2) and
graphically (Figure E1).
Table 2 reports the results of the meta-analyses for the
specific outcomes. For all 11 outcomes we find an estimated
OR less than 1 in favor of off-pump surgery. This effect is
highly significant (P< .0001) for the outcomes mortality,
stroke, renal failure, and RBC transfusion; significant forThe Journal of Thoracic and Cawound infection (P< .001), prolonged ventilation (P<
.01), intraaortic balloon pump support (P ¼ .01) and inotro-
pic support (P ¼ .02); and borderline significant for reoper-
ation for bleeding (P ¼ .06). Insignificant ORs near 1 were
observed for myocardial infarction and atrial fibrillation. Es-
timates from the fixed effects model differed only slightly
from the random effect estimates. Heterogeneity of studies
for the different outcomes varied widely. A very large het-
erogeneity was found for the outcomes inotropic support
and RBC transfusion, and large heterogeneity for reopera-
tion and atrial fibrillation. All other outcomes showed at
most moderate or no heterogeneity.
In meta-regression, heterogeneity of treatment effects
could not be explained by the study location (Northern
America vs Europe, P¼ .33), type of propensity score anal-
ysis (matching vs nonmatching, P ¼ .99), population risk
(high risk vs standard, P ¼ .65), volume per year (P ¼
.55), or percentage of off-pump cases in the general study
population (P ¼ .25).DISCUSSION
Our systematic review and meta-analysis of propensity
score analyses finds off-pump surgery superior to on-pump
surgery with respect to all of the assessed short-termrdiovascular Surgery c Volume 140, Number 4 831
TABLE 1. Included studies
PS analysis population General population
Study
Observation
period
Study
location
Study
centers (no.)
Are patients
from a high-risk
group
(as reported from
the authors)?
If yes, which risk?
Average patient
age, y
Gender
(% male)
Proportion of
off-pump
cases (%)
Proportion of
off-pump
cases (%)
Ascione 2002 04/96–04/01 England 1 Overweight (BMI  25) 63.0 79.5 23.7 (674/2844) 23.7 (674/2844)
Ascione 2003 04/96–08/02 England 1 Severe LV dysfunction (EF<30%) 65.3 90.4 29.6 (74/250) 29.6 (74/250)
Boening 2003 01/98–12/01 Germany 1 No 65.5 – 42.6 (72/169) 20.5 (133/650)
Calafiore 2003a 11/94–12/01 Italy 1 No 64.4 83.2 50.0 (961/1922) –
Calafiore 2003b 11/94–12/01 Italy 1 EuroSCORE  6 70.1 71.7 50.0 (510/1020) –
Calafiore 2005 11/94–12/01 Italy 1 No 62.6 86.1 50.0 (597/1194) –
Chukwuemeka 2005 00/95–00/03 Canada 1 Preoperative renal dysfunction 70.3 64.4 25.0 (146/584) 5.5 (158/2869)
Frankel 2005 01/98–06/02 USA 1 No – – 50.0 (2141/4282) 41.2(3646/8843)
Grunkemeier 2002 00/98–00/00 USA 9 No 66.5 73.1 31.8 (990/3110) 15.0 (1194*/7955)
Ivanov 2006 00/96–00/02 Canada 1 No – – 50.0 (503/1006) 4.5 (514/11368)
Karthik 2003 04/97–03/02 England 2 Nonelective CABG 65.0 72.4 50.4 (417/828) 48.1 (1813/3771)
Karthik 2004 04/97–03/02 England 2 Peripheral vascular disease 65.6 79.4 50.0 (211/422) 48.1 (1813/3771)
Lamy 2005 03/01–12/02 Canada 14 No 64.6 – 50.0 (1233/2466) 49.5 (1657/3350)
Lee 2006 07/99–01/04 Canada 1 No – – 50.0 (165/330) 48.1 (290/603)
Lu 2005 04/97–04/03 Great Britain 1 LMS disease 65.7 80.5 21.6 (259/1197) 21.6 (259/1197)
Mack 2004a 00/99–00/01 USA 4 Multivessel disease – – 50.0 (5774/11548) 41.9 (7283/17401)
Mack 2004b 01/98–03/02 USA 82 Women 68.8 0.0 50.0 (3688/7376) 19.4 (4250/21902)
Magee 2002 01/98–07/00 USA 2 Multivessel disease – – 33.3 (1606*/4818) 23.5 (1983/8449)
Magee 2003 01/99–12/00 USA – >2 grafts 68.0 68.6 50.0 (16937/33874) 8.8 (17969/204602)
Meco 2004 – Italy – Age>75 y – – 65.5 (78/119) –
Oo 2003 04/97–09/02 England 1 EuroSCORE  6 71.4 72.6 50.4 (196/389) –
Pandey 2005 04/97–09/02 England 1 No 61.9 80.8 50.0 (360/720) 17.4 (987/5679)
Patel 2002a 04/97–05/01 England 2 No 62.0 78.1 48.0 (1117/2327) 48.0 (1117/2327)
Patel 2002b 04/97–03/01 England 4 No 62.8 79.1 7.7 (843/10941) 7.7 (843/10941)
Sabik 2002 01/97–06/00 USA 1 No 66.0 69.5 50.0 (406/812) 13.0 (481/3712)
Saunders 2004 00/96–00/02 USA 1 Functional mitral regurgitation – – 50.0 (127/254) 20.6 (222/1078)
Seif 2005 00/93–00/04 USA 1 No – – 25.0 (1913/7641) –
Sharony 2004 06/93–10/02 USA 1 Atheromatous aortic disease 73.0 68.8 50.0 (245/490) 28.5 (281/985)
Srinivasan 2004 04/97–09/02 England 1 Diabetes 65.2 77.0 19.6 (186/951) 19.6 (186/951)
Stamou 2002 06/94–12/00 USA 1 No – – 50.0 (1670/3340) 22.3 (2320/10389)
Stamou 2004 10/98–06/01 USA 1 No – – 50.0 (1833*/3666*) 44.6 (2477/5554)
Stamou 2005 01/00–12/00 USA 1 Parsonnet score  20 points 71.0 48.3 61.4 (315/513) 61.4 (315/513)
Stamou 2006 01/00–10/03 USA 2 Nonelective CABG – – 50.0 (2013/4026) 36.3 (2273/6260)
Weerasinghe 2005 01/01–11/03 England 3 Multivessel disease 64.5 73.7 40.0 (817/2041) 40.0 (817/2041)
Williams 2005 01/98–09/03 USA 1 No 63.5 69.8 11.3 (641/5667) 11.3 (641/5667)
BMI, Body mass index; LV, left ventricular; EF, ejection fraction; CABG, coronary artery bypass grafting; LMS, left main stem stenosis. *Numbers estimated from the text.
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TABLE 2. Results of meta-analyses
Response
No. of studies
(patients) OR (95% CI) P value, REM
P value
homogeneity I2 (%) NNT (95% CI) OR (95% CI) P value, FEM
Mortality 28 (100,066) 0.69 (0.60–0.75) P< .0001 .18 14 189 (155–251) 0.70 (0.65–0.76) P< .0001
Stroke 22 (55,290) 0.42 (0.33–0.54) P< .0001 .16 16 104 (90–132) 0.49 (0.41–0.58) P< .0001
Myocardial infarction 14 (35,951) 0.97 (0.73–1.30) P ¼ .86 .06 32 2685 (254 to229) 0.91 (0.74–1.11) P ¼ .35
Atrial fibrillation 11 (29,343) 0.92 (0.80–1.05) P ¼ .20 .01 51 79 (33 to143) 0.85 (0.80–0.91) P< .0001
Renal failure 17 (38,866) 0.60 (0.51–0.70) P< .0001 .21 11 82 (67–110) 0.59 (0.53–0.66) P< .0001
Inotropic support 7 (6,153) 0.59 (0.38–0.90) P ¼ .02 P< .0001 82 8 (5–41) 0.65 (0.56–0.75) P< .0001
RBC transfusion 8 (16,685) 0.36 (0.25–0.54) P< .0001 P< .0001 91 9 (7–13) 0.49 (0.44–0.54) P< .0001
Wound infection 13 (33,030) 0.59 (0.45–0.77) P< .001 .97 0 314 (235–553) 0.59 (0.45–0.77) P< .0001
Reoperation for bleeding 14 (39,480) 0.76 (0.57–1.02) P ¼ .06 <.01 50 195 (107 to2753) 0.69 (0.59–0.81) P< .0001
IABP support 7 (9703) 0.60 (0.41–0.89) P ¼ .01 .18 10 245 (164–904) 0.57 (0.43–0.76) P< .001
Prolonged ventilation 6 (8675) 0.71 (0.56–0.89) P< .01 .32 0 116 (77–312) 0.74 (0.61–0.90) P ¼ .002
OR, Odds ratio; CI, confidence interval; REM, random effects model; NNT, number needed to treat; FEM, fixed effects model; RBC, red blood cell; IABP, intraaortic balloon pump.
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Doutcomes. This advantage was statistically significant and
clinically relevant for most outcomes, especially for the
most valid outcome of mortality. This study is the first to
systematically collect evidence only from propensity score
analyses, a statistical technique for analyzing nonrandom-
ized trials that finds increasing use in cardiac surgery and
that is especially suited for situations with rare outcomes.
Our results have to be compared with the existing knowl-
edge on the topic, especially with previous meta-analyses of00,0100,101,0
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FIGURE 2. Results from previous meta-analyses of RCTs, observational studi
the meta-analyses of RCTs, we give the results from the most recent meta-analys
meta-analyses reported relative risks, we recalculated the OR by using the formu
study; PS, propensity score; RBC, red blood cell; OP, operation; IABP, intraaor
The Journal of Thoracic and Carandomized3-5 and nonrandomized trials5 (Figure 2). It
should be noted that there is only a small overlap (n ¼ 7)
of our studies and the observational studies included in
Wijeysundera and colleagues’5 review. As such, our results
can be considered roughly independent of Wijeysundera and
colleagues’ results. Compared with the results of random-
ized trials, our results are not contradictory; our estimates
are well within the CIs of estimates from randomized trials.
Of course, CIs from RCTs are larger, reflecting smaller00,0100,101,0
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es. Results are shown as ORs with 95% CIs. In cases for which the previous
la of Zhang and Yu.21 RCT, Randomized clinical trial; OBS, observational
tic balloon pump; CI, confidence interval.
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Dsample sizes. We also expect randomized trials to be per-
formed in selected populations, and certain differences be-
tween RCTs and our propensity score analyses are not
surprising. Compared with previous nonrandomized trials,
there is agreement in most of the outcomes. But we also
find a nonoverlapping CI for stroke and only succinct over-
lapping intervals for atrial fibrillation and RBC transfusion.
It should be noted, however, that the large sample sizes in
both Wijeysundera and colleagues’ review and our study
guarantee small CIs, and not all significant differences can
be considered clinically relevant.
Our systematic review, which is the first to explicitly in-
clude only propensity score analyses, also contributes to
the body of methodical knowledge. Only approximately
70% of the studies were found in the standard literature da-
tabases. This underlines the importance of a free web search
and, especially important for propensity score analyses, cita-
tion tracking of classic articles describing the propensity
score method. We were not surprised by the results of our
meta-regression on the influence of type of propensity score
analysis. Although current guidelines favor the use of
matching,22 we found no differences between studies using
matching and those using other techniques for adjusting for
the propensity score. This was already stressed in the initial
propensity score article by Rosenbaum and Rubin.9 How-
ever, and somewhat contrary to common perception, there
were no differences in effects from high-risk and low-risk
populations.
Any systematic review and meta-analysis is vulnerable to
publication bias, that is, the selective reporting of trials de-
pending on study results. Funnel plots were proposed to
graphically assess publication bias. We drew funnel plots
for all our outcomes. All plots indicated no publication
bias (Figure E2). Moreover, because the comparison be-
tween off- and on-pump in CABG is such a hotly debated
issue,2 we expect most (or hopefully all) of the studies to
be submitted and published, as predicted by Sedrakyan
and colleagues.3
Study Limitations
Our study has some limitations. We reported only short-
term outcomes; data on graft patency or revascularization
rates are missing. This is problematic because new evidence
suggests that the on-pump technique may result in better
graft patency.23 Graft patency data were omitted because
they are rarely reported, and patients frequently are lost to
follow-up.
It is tempting to speculate why most of the CABG proce-
dures are still performed on-pump. Off-pump surgery is
technically more demanding than the on-pump technique
performed under cardioplegic arrest. Only a small number
of centers train their staff in the former technique. Therefore,
off-pump surgery is part of just a limited number of a sur-
geon’s armamentarium. This contrasts with the experience834 The Journal of Thoracic and Cardiovascular Surgin other centers, for example, Emory University in Atlanta,
where more than 80% of surgical revascularizations are per-
formed off-pump.24 In countries such as Japan or India, the
percentage is greater than 50%.25 Authors from these coun-
tries have demonstrated that an off-pump program can be es-
tablished without risk and with good patient outcomes. As
we show in our article, the evidence remains ambiguous at
this time. This is also reflected in the American Heart Asso-
ciation’s scientific statement article.2 Lack of a compelling
indication is certainly a significant reason for not abandon-
ing the standard technique in favor of one that is highly
challenging.CONCLUSIONS
Current evidence from nonrandomized trials of any de-
sign suggests that off-pump CABG is superior, at least
with respect to short-term outcomes. This finding is in line
with the collected evidence from the present randomized tri-
als. In the future, large ongoing randomized trials, among
them the CORONARY trial from Canada (4700 patients
planned, expected end of recruiting phase: May 2014,
ClinicalTrials.gov Identifier: NCT00463294) and the
ROOBY trial26 (2200 patients planned, expected end of
recruiting phase: November 2008) will contribute to the
definite answer. Long-term follow-up of patients from
current trials will provide additional evidence.
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FIGUREE1. Forest plots for all outcomes. To enhance readability, x-axes are only drawn from 0.1 to 10. CIs having values outside this range are marked by
an asterisk (*). CI, Confidence interval; RBC, red blood cell; IABP, intraaortic balloon pump.
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FIGURE E2. Funnel plots for all outcomes. SQRT, Square root; OR, odds ratio; IABP, intraaortic balloon pump.
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TABLE E2. Results from the single studies
Mortality
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.37 (0.18–0.77) 2.29 1.32
Ascione 2003 1.45 (0.51–4.17) 1.15 0.63
Boening 2003 2.74 (0.24–30.9) 0.23 0.12
Calafiore 2003a 0.41 (0.21–0.79) 2.77 1.63
Calafiore 2003b 0.52 (0.28–0.96) 3.04 1.82
Calafiore 2005 0.63 (0.24–1.64) 1.38 0.77
Chukwuemeka
2005
0.90 (0.24–3.31) 0.76 0.41
Ivanov 2006 0.71 (0.22–2.26) 0.96 0.52
Karthik 2003 0.83 (0.36–1.93) 1.76 0.99
Karthik 2004 0.98 (0.35–2.75) 1.20 0.66
Lamy 2005 0.90 (0.48–1.69) 2.96 1.76
Lu 2005 0.95 (0.41–2.18) 1.77 1.00
Mack 2004a 0.54 (0.43–0.68) 12.35 13.25
Mack 2004b 0.81 (0.63–1.04) 11.39 11.29
Magee 2002 0.53 (0.32–0.83) 4.73 3.07
Magee 2003 0.83 (0.72–0.96) 17.83 35.88
Meco 2004 0.09 (0.01–0.83) 0.28 0.15
Oo 2003 0.57 (0.21–1.56) 1.26 0.69
Pandey 2005 0.39 (0.12–1.27) 0.94 0.51
Patel 2002b 0.59 (0.31–1.12) 2.86 1.69
Sabik 2002 0.50 (0.09–2.73) 0.45 0.24
Saunders 2006 0.87 (0.30–2.47) 1.16 0.64
Sharony 2004 0.54 (0.29–1.03) 2.86 1.70
Srinivasan 2004 0.53 (0.18–1.55) 1.10 0.60
Stamou 2004 0.63 (0.50–0.83) 11.08 10.72
Stamou 2005 0.48 (0.23–0.98) 2.29 1.32
Stamou 2006 0.81 (0.57–1.15) 7.48 5.67
Williams 2005 0.53 (0.22–1.24) 1.66 0.93
Stroke
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Calafiore 2003a 0.26 (0.09–0.80) 4.21 2.68
Calafiore 2003b 0.18 (0.05–0.63) 3.48 2.14
Calafiore 2005 1.25 (0.33–4.69) 3.12 1.89
Chukwuemeka
2005
0.00 (0.00–>100) 0.00 0.00
Grunkemeier
2002
0.37 (0.17–0.77) 7.64 5.86
Ivanov 2006 0.11 (0.01–0.87) 1.37 0.77
Karthik 2003 0.36 (0.08–1.53) 2.56 1.51
Karthik 2004 0.09 (0.02–0.50) 2.19 1.27
Lamy 2005 0.49 (0.23–1.06) 7.43 5.63
Lee 2006 0.14 (0.02–1.13) 1.33 0.74
Lu 2005 0.17 (0.02–1.31) 1.35 0.75
Mack 2004a 0.64 (0.48–0.85) 18.56 40.44
Oo 2003 0.17 (0.03–0.93) 1.94 1.11
Pandey 2005 0.00 (0.00–>100) 0.00 0.00
Patel 2002a 0.24 (0.08–0.74) 4.16 2.64
(Continued)
Table E2. Continued
Stroke
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Patel 2002b 0.26 (0.09–0.70) 4.77 3.12
Sabik 2002 0.60 (0.14–2.51) 2.68 1.59
Sharony 2004 0.27 (0.09–0.84) 4.09 2.59
Srinivasan 2004 0.15 (0.02–0.96) 1.56 0.88
Stamou 2002 0.56 (0.33–1.00) 11.09 10.69
Stamou 2006 0.60 (0.33–1.08) 10.28 9.35
Williams 2005 0.78 (0.33–1.87) 6.19 4.37
Myocardial infarction
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 2.29 (0.91–5.76) 6.59 4.86
Ascione 2003 1.61 (0.71–3.85) 7.38 5.79
Boening 2003 1.01 (0.22–4.66) 3.05 1.77
Calafiore 2003a 0.66 (0.30–1.48) 7.83 6.39
Calafiore 2003b 0.76 (0.33–1.76) 7.51 5.96
Calafiore 2005 1.51 (0.42–5.36) 4.14 2.57
Chukwuemeka
2005
1.13 (0.43–2.94) 6.27 4.52
Karthik 2003 0.72 (0.26–1.98) 5.79 4.02
Karthik 2004 0.96 (0.24–3.92) 3.55 2.12
Lamy 2005 2.09 (1.18–3.69) 11.18 12.74
Mack 2004a 0.58 (0.40–0.85) 14.80 29.60
Patel 2002b 0.81 (0.44–1.51) 10.42 10.89
Sabik 2002 0.60 (0.14–2.51) 3.38 2.00
Srinivasan 2004 0.68 (0.31–1.48) 8.11 6.78
Atrial fibrillation
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.73 (0.51–1.04) 7.95 3.25
Ascione 2003 0.85 (0.39–1.87) 2.45 0.67
Calafiore 2003a 0.64 (0.49–0.84) 10.61 5.70
Calafiore 2003b 0.79 (0.56–1.12) 8.25 3.47
Karthik 2003 1.30 (0.89–1.88) 7.51 2.95
Karthik 2004 1.39 (0.84–2.30) 5.03 1.63
Lu 2005 1.11 (0.81–1.53) 9.03 4.08
Mack 2004a 0.79 (0.73–0.87) 17.64 54.44
Pandey 2005 1.03 (0.73–1.45) 8.43 3.60
Seif 2005 0.91 (0.78–1.07) 15.05 16.89
Srinivasan 2004 1.21 (0.85–1.72) 8.06 3.32
Renal failure
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.90 (0.44–1.85) 4.20 2.50
Ascione 2003 0.70 (0.28–1.79) 2.64 1.50
Calafiore 2003a 0.80 (0.31–2.03) 2.61 1.48
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Renal failure
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Chukwuemeka
2005
0.81 (0.22–2.96) 1.42 0.77
Karthik 2003 0.44 (0.22–0.90) 4.34 2.60
Karthik 2004 0.59 (0.26–1.34) 3.31 1.92
Lamy 2005 0.23 (0.08–0.69) 2.00 1.11
Lu 2005 0.92 (0.42–1.98) 3.66 2.14
Mack 2004a 0.50 (0.41–0.61) 22.42 32.79
Mack 2004b 1.07 (0.64–1.78) 7.48 4.99
Oo 2003 0.35 (0.14–0.89) 2.66 1.51
Pandey 2005 0.61 (0.25–1.48) 2.83 1.62
Sabik 2002 0.00 (0.00–>100) 0.00 0.00
Sharony 2004 0.66 (0.23–1.88) 2.10 1.17
Srinivasan 2004 0.38 (0.16–0.94) 2.88 1.64
Stamou 2006 0.52 (0.37–0.72) 13.57 11.63
Weerasinghe
2005
0.69 (0.56–0.85) 21.87 30.64
Inotropic support
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.81 (0.63–1.03) 16.71 35.80
Ascione 2003 0.22 (0.08–0.56) 9.33 2.29
Boening 2003 1.33 (0.71–2.47) 12.92 5.57
Chukwuemeka
2005
1.27 (0.87–1.85) 15.59 15.35
Lu 2005 0.49 (0.35–0.69) 15.93 18.78
Oo 2003 0.35 (0.21–0.59) 14.11 8.11
Pandey 2005 0.33 (0.23–0.49) 15.42 14.10
RBC transfusion
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.40 (0.30–0.52) 12.98 13.27
Calafiore 2003b 0.59 (0.42–0.81) 12.63 9.26
Frankel 2005 0.50 (0.39–0.58) 13.38 25.49
Oo 2003 0.12 (0.07–0.22) 10.72 3.06
Pandey 2005 0.15 (0.10–0.23) 11.93 5.56
Sabik 2002 0.64 (0.48–0.84) 12.97 13.05
Srinivasan 2004 0.21 (0.14–0.32) 12.02 5.88
Williams 2005 0.80 (0.66–0.99) 13.36 24.42
Wound infection
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.83 (0.42–1.66) 14.96 14.96
Ascione 2003 0.84 (0.16–4.55) 2.52 2.52
Boening 2003 1.00 (0.00–>100) 0.01 0.01
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Wound infection
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Chukwuemeka
2005
0.86 (0.18–4.16) 2.82 2.82
Karthik 2004 0.50 (0.11–2.33) 3.03 3.03
Lu 2005 0.73 (0.33–1.61) 11.25 11.25
Mack 2004a 0.54 (0.31–0.97) 21.33 21.33
Mack 2004b 0.50 (0.21–1.17) 9.78 9.78
Pandey 2005 0.41 (0.19–0.92) 11.17 11.17
Sabik 2002 0.12 (0.02–0.99) 1.63 1.63
Sharony 2004 0.50 (0.04–5.53) 1.22 1.22
Srinivasan 2004 0.65 (0.29–1.42) 11.20 11.20
Williams 2005 0.56 (0.23–1.34) 9.10 9.10
Reoperation for bleeding
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.56 (0.28–1.10) 8.50 5.12
Ascione 2003 0.50 (0.10–2.50) 2.66 0.92
Boening 2003 0.44 (0.04–4.33) 1.44 0.46
Frankel 2005 0.80 (0.53–1.24) 12.10 13.26
Karthik 2003 1.72 (0.73–4.04) 6.68 3.27
Karthik 2004 1.03 (0.27–3.95) 3.58 1.33
Lu 2005 1.39 (0.63–3.07) 7.30 3.82
Mack 2004a 0.46 (0.35–0.60) 14.39 32.94
Pandey 2005 0.56 (0.23–1.36) 6.45 3.08
Patel 2002b 1.45 (0.90–2.31) 11.41 10.78
Sabik 2002 0.69 (0.26–1.84) 5.67 2.52
Sharony 2004 0.12 (0.02–0.98) 1.69 0.55
Srinivasan 2004 0.74 (0.25–2.23) 4.85 2.00
Stamou 2006 0.70 (0.50–1.00) 13.29 19.94
IABP support
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.39 (0.14–1.15) 10.73 7.49
Ascione 2003 1.59 (0.57–4.55) 10.96 7.69
Boening 2003 0.01 (0.00–>100) 0.04 0.02
Karthik 2003 0.44 (0.21–0.96) 17.03 14.37
Lu 2005 1.07 (0.52–2.18) 18.33 16.16
Oo 2003 0.48 (0.19–1.23) 12.85 9.52
Stamou 2006 0.46 (0.30–0.71) 30.06 44.74
Prolonged ventilation
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Ascione 2002 0.86 (0.67–1.10) 47.62 59.46
Karthik 2003 0.58 (0.31–1.08) 12.10 9.38
Lamy 2005 0.61 (0.36–1.04) 16.24 13.18
Lu 2005 0.83 (0.43–1.61) 10.94 8.39
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Table E2. Continued
Prolonged ventilation
Study OR (95% CI)
Relative
weight (%),
RE
Relative
weight (%),
FE
Oo 2003 0.36 (0.15–0.86) 6.54 4.79
Srinivasan 2004 0.52 (0.22–1.26) 6.55 4.80
OR, Odds ratio; CI, confidence interval; RE, random effect; FE, fixed effect; RBC, red
blood cell; IABP, intraaortic balloon pump. Given are the odds ratios (with 95% CI)
and the relative weights (in %) with which the respective studies were weighted in
the overall random effect or fixed effect estimator.
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